OPHTHALMOLOGY

we are dedicated to advancing eye care through innovative and impactful clinical research in ophthalmology. Vision-related disorders affect people across all age groups and can significantly reduce quality of life. Through collaboration with leading ophthalmologists, research institutions, and sponsors, we support the development of breakthrough therapies aimed at preserving and restoring vision.

Our ophthalmology research program encompasses a wide spectrum of eye diseases, with a strong focus on precision diagnostics, advanced imaging, and patient-centered outcomes.

ophthalmology

Core Focus Areas:

  • Age-Related Macular Degeneration (AMD) – both dry and wet forms
  • Diabetic Retinopathy and Diabetic Macular Edema
  • Glaucoma
  • Retinitis Pigmentosa and Other Inherited Retinal Disorders
  • Uveitis and Ocular Inflammation
  • Dry Eye Disease and Ocular Surface Disorders
  • Refractive Errors and Myopia Control
  • Post-Surgical Outcomes and Innovations in Ocular Drug Delivery

Our Research Expertise:

  • Evaluation of anti-VEGF therapies, gene therapies, and slow-release ocular implants
  • Trials focused on minimally invasive glaucoma surgeries (MIGS) and laser treatments
  • Use of advanced ophthalmic imaging (OCT, fundus photography, fluorescein angiography)
  • Studies assessing the impact of digital devices and blue light exposure on eye health
  • Investigation of novel diagnostics and biomarkers for early disease detection

Our Ophthalmology Trial Infrastructure:

  • Specialized Ophthalmic Sites equipped with diagnostic and surgical tools
  • Central Laboratory Services for ocular fluid analysis and genetic testing
  • Electronic Data Capture (EDC) tailored for ophthalmic endpoints
  • IVRS/IWRS Systems for efficient patient randomization and supply logistics
  • CTMS for streamlined trial tracking, documentation, and compliance
  • Protocols developed with a strong emphasis on patient comfort and retention

At Tupalin Research, we are helping bring the future of vision science into focus—supporting therapies that aim not only to slow the progression of eye diseases but also to restore sight and improve lives.